The Medicines Company is seeking late stage partnerships in Acute Care
The Medicines Company business development
The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. They acquire, develop and commercialize pharmaceutical products in late stages of their development. They focus their commercial and product development resources primarily on the U.S. hospital market.
They intend to continue building their acute care franchise of hospital products by selectively acquiring and developing late-stage product candidates or products approved for marketing.
They seek product licensing deals with larger pharmaceutical companies in the process of refining their own product portfolios and from smaller companies seeking specialist development or commercial collaborations.
In evaluating product acquisition candidates, they will continue to seek products that have the potential to alleviate the growing pressures on U.S. hospitals to treat patients more efficiently.
In general, they look for:
- an anticipated time from acquisition to commercialization of four years or less
- existing clinical data which provides reasonable evidence of safety and efficacy
- the potential to reduce a patient's hospital stay. In addition, we may acquire approved products that can be marketed in hospitals by our commercial organization.